Esketamine monotherapy demonstrated beneficial antidepressant effects at multiple doses for patients with treatment-resistant depression, according to results of a phase 4 randomized trial published ...

Researchers at Radboud University and the Radboudumc found that mothers with postpartum depression benefit from oxytocin nasal spray. The oxytocin causes mothers to respond more positively to their ...

A nasal spray for treatment-resistant depression has delivered strong clinical results and rekindled investor hopes.

Research on synthetic psychedelics progresses, and there's hope to prove psilocybin safe and effective in intractable depression. The HHS and FDA voice support for psychedelics.

Credence Behavioral Health opened its doors in Lynchburg. Now, the outpatient clinic is serving over 1,700 patients, and ...

ABBV's neuroscience sales are projected to jump 15% in Q2, driven by Botox Therapeutic, Vraylar and oral migraine drug gains.

Dividend stocks are one of the most powerful investing tools to build wealth. The S&P 500 has plenty of magnificent dividend ...

After drowning in his hot tub at 54, Matthew Perry's doctor pleaded guilty to distributing the drug that helped kill him.

Fragrance has entered the wellness and aromatherapy space. Discover the new scents designed to lower stress levels and ...

“The opioids, Carfentanil and fentanyl, they actually cause what’s called respiratory depression,” Bagdasarian said. “They ...

Steven Pfanstiel, a seasoned financial executive with extensive medical technology and pharmaceutical experience, replaces Steve Furlong as Chief Financial Officer following previously announced ...

Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide) nasal spray, today ...